Glutathione Research Guide
Antioxidant research compound
Glutathione (GSH) is the most abundant intracellular antioxidant in mammalian cells, central to detoxification, redox balance, and cellular defense against oxidative damage. Its cellular concentration declines with age and metabolic stress, making it a focal point for oxidative-stress and longevity research.
Contents
|
Tripeptide Gly-Cys-Glu |
Master antioxidant Intracellular |
Redox cycling GSH ↔ GSSG |
What is Glutathione?
Glutathione is a tripeptide composed of glycine, cysteine, and glutamate, synthesized endogenously in nearly all cell types. It exists in two interconvertible forms: reduced (GSH) and oxidized (GSSG, glutathione disulfide). The ratio of GSH to GSSG is one of the most-cited markers of cellular redox status.
Beyond its direct antioxidant role, glutathione is the substrate for glutathione peroxidase (which detoxifies hydrogen peroxide), glutathione S-transferase (which conjugates electrophilic toxins for elimination), and several other detoxification enzymes. Cellular glutathione thus links general antioxidant capacity, xenobiotic metabolism, and protein function.
Aeternum Labs supplies Glutathione as a lyophilized powder verified to 99%+ purity by HPLC. Each batch ships with a publicly published Certificate of Analysis.
Mechanism of action
GSH neutralizes reactive oxygen species (hydroxyl radical, peroxynitrite, lipid peroxides) through direct chemistry — the cysteine thiol group donates an electron, neutralizing the radical and converting GSH to GSSG. Glutathione reductase then converts GSSG back to GSH using NADPH as the reducing equivalent.
Beyond direct antioxidant activity, GSH conjugates electrophilic toxins through glutathione S-transferase activity, generating water-soluble conjugates that can be excreted by the kidneys or via the bile. This is a major pathway for elimination of xenobiotics including many drug metabolites and environmental toxicants.
GSH also regulates redox-sensitive transcription factors (Nrf2, NF-kB) and post-translational protein modifications (glutathionylation) that act as redox switches on enzyme activity. The integrated effect places GSH at the center of cellular response to oxidative stress.
Research history
Glutathione was first isolated by Frederick Gowland Hopkins in 1921, work that contributed to his Nobel Prize in 1929. The tripeptide structure (gamma-glutamyl-cysteinyl-glycine) was characterized through the 1930s, and the role in antioxidant defense was established through the mid-20th century.
Research on glutathione’s role in aging and disease accelerated through the 1990s and 2000s, with measurable declines in cellular GSH identified as a feature of multiple age-related conditions. The therapeutic potential of restoring cellular GSH has been a continuous research focus since.
Modern research includes oral bioavailability investigations (problematic due to gut degradation), IV administration in clinical settings, and precursor-based strategies (N-acetylcysteine, glycine, glutamine supplementation) to support endogenous synthesis.
Half-life and pharmacokinetics
Direct administration of glutathione in research uses intravenous, intramuscular, subcutaneous, and (less commonly) oral routes. Oral bioavailability is limited because GSH is degraded in the gut before reaching systemic circulation.
Plasma half-life of administered GSH is short (under one hour), but downstream effects on cellular redox status persist for hours as cells internalize and utilize available glutathione substrates.
Typical research doses
Research dose ranges for direct GSH administration span 200 mg to 2 g per administration, with frequencies ranging from daily during acute oxidative-stress challenge studies to weekly or biweekly maintenance protocols.
Precursor-based research using N-acetylcysteine typically uses 600-1800 mg orally daily to support endogenous GSH synthesis. Combination protocols using direct GSH plus precursors are also documented.
Compliance reminder
All dose ranges discussed are reported from peer-reviewed in vitro and animal research. They are not human-use dose recommendations.
Reconstitution protocol
Lyophilized peptides require reconstitution with a sterile solvent before any in vitro work. The standard solvent across virtually all research-peptide protocols is bacteriostatic water (sterile water with 0.9% benzyl alcohol), which prevents microbial growth across the typical four-week working window once a vial is opened.
Add the solvent slowly down the inside wall of the vial rather than directly onto the lyophilized cake. Swirl gently until the powder dissolves fully. Do not shake — agitation can denature peptide bonds and reduce assay potency. A clear, particle-free solution should result within thirty to sixty seconds.
Volume calculations are straightforward. For a 10 mg vial reconstituted with 2 mL of bacteriostatic water, each 0.1 mL of the resulting solution contains 0.5 mg of peptide. Researchers planning multi-week protocols should compute their volumes ahead of time and document the lot number against each preparation.
Storage and stability
Sealed lyophilized vials are stable at 0°F (−18°C) for up to twenty-four months in most research literature. Vials should be kept dry, light-protected, and away from temperature fluctuations. Avoid storing peptides in the freezer door, where each open-close cycle introduces thermal stress.
Once reconstituted, store the working solution at 36–46°F (2–8°C). Most lyophilized peptides remain stable in solution for twenty-eight days under refrigeration with bacteriostatic water as the diluent. For protocols longer than four weeks, reconstitute fresh batches as needed rather than extending a single working vial.
Repeated freeze-thaw cycles reduce peptide integrity. If long-term storage of a reconstituted sample is required, aliquot the solution into single-use volumes before freezing so each thaw uses a fresh aliquot.
Glutathione is particularly oxidation-sensitive. Light-protected storage and avoidance of repeated freeze-thaw cycles are important. Working solutions should ideally be prepared fresh from frozen stock.
Common stack pairings
Glutathione + NAD+ (cellular redox + energy research)
GSH manages oxidative defense while NAD+ supports energy metabolism and DNA repair. The combination is researched for general cellular function endpoints in aging-related study designs.
How it compares
Compared to N-acetylcysteine: NAC is an orally bioavailable precursor that supplies cysteine (the rate-limiting amino acid in GSH synthesis), supporting endogenous GSH production. Direct GSH administration bypasses the synthesis step but requires non-oral routes.
Compared to vitamin C: Both are antioxidants, but they operate in different cellular compartments (GSH primarily intracellular, vitamin C primarily extracellular) and have different mechanisms. They are complementary rather than redundant in research designs.
From the Aeternum library
Glutathione
- 99%+ purity verified by HPLC
- LAL endotoxin screening
- Full Certificate of Analysis published
- Light-protected packaging
- Lyophilized powder
Frequently asked questions
Why is glutathione called the master antioxidant?
GSH is the most abundant intracellular antioxidant and is the substrate for glutathione peroxidase, glutathione S-transferase, and the cellular redox cycling system. Its central role in coordinating cellular antioxidant defense across multiple enzyme systems is what earned it the ‘master antioxidant’ designation in the literature.
Why doesn't oral glutathione work well?
Oral GSH is largely degraded in the gut before reaching systemic circulation, with low bioavailability. Direct administration via IV or other parenteral routes bypasses this limitation. Precursor-based approaches (N-acetylcysteine) are also commonly used to support endogenous GSH synthesis through cysteine supplementation.
What is the relationship between GSH and GSSG?
GSH (reduced) and GSSG (oxidized, glutathione disulfide) interconvert during antioxidant activity. The ratio of GSH:GSSG is one of the most-used markers of cellular redox status — high ratios indicate healthy reducing conditions, low ratios indicate oxidative stress.
What dose ranges are used in research?
Direct GSH research administration uses 200 mg to 2 g per administration. Precursor-based research with N-acetylcysteine uses 600-1800 mg orally daily. Frequencies vary from daily during acute oxidative-stress studies to weekly maintenance protocols.
How is glutathione stored?
GSH is oxidation-sensitive. Sealed lyophilized vials are stored at 0°F (−18°C) in light-protected packaging for long-term stability. Working solutions should ideally be prepared fresh from frozen stock rather than stored long-term in solution.
References
- Forman HJ, Zhang H, Rinna A (2009). Glutathione: overview of its protective roles, measurement, and biosynthesis. View source
- Pizzorno J (2014). Glutathione!. View source
- Lu SC (2013). Glutathione synthesis. View source
Reviewed by
The Aeternum Labs Research Team
Compounds, COAs, and protocol design
The Aeternum Labs research team verifies every batch in our library against published purity and identity standards. Articles in our research blog summarize publicly available scientific literature and are reviewed for accuracy by team members trained in peptide biochemistry and laboratory protocol design.
Related research
Category
Best peptides for longevity research →
Pair with
NAD+ research guide →
Research Disclaimer. All compounds discussed in this article are sold by Aeternum Labs for in vitro laboratory research purposes only. They are not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease or condition. Information presented is summarized from publicly available scientific literature and should not be construed as medical advice.